ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,904.74
1.44%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.911
-0.04%
Brent Oil
81.925
0.76%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) ニュース

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0J7G
日付受信時刻ニュースソース見出しコード企業名
2024/01/1116 : 00RNS Non-RegulatoryHutchmed (China) Limited Sovleplenib NDA Granted Priority Review in ChinaLSE:0J7GHutchison China Meditech Ltd
2023/12/2917 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
2023/12/2917 : 30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
2023/12/2119 : 00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:0J7GHutchison China Meditech Ltd
2023/12/1316 : 00RNS Non-RegulatoryHutchmed (China) Limited Completed Enrollment of Phase II/III TrialLSE:0J7GHutchison China Meditech Ltd
2023/12/1316 : 00RNS Non-RegulatoryHutchmed (China) Limited Inclusion in National Reimbursement Drug ListLSE:0J7GHutchison China Meditech Ltd
2023/12/0719 : 04UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:0J7GHutchison China Meditech Ltd
2023/12/0116 : 00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at CongressesLSE:0J7GHutchison China Meditech Ltd
2023/11/3017 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
2023/11/0916 : 00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)LSE:0J7GHutchison China Meditech Ltd
2023/10/2417 : 30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPLSE:0J7GHutchison China Meditech Ltd
2023/10/1617 : 30RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO 2023LSE:0J7GHutchison China Meditech Ltd
2023/09/2917 : 30RNS Non-RegulatoryHutchmed (China) Limited NDA Submission for Fruquintinib in JapanLSE:0J7GHutchison China Meditech Ltd
2023/09/2917 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
2023/09/1417 : 30UK RegulatoryHutchmed (China) Limited Director's Share DealingLSE:0J7GHutchison China Meditech Ltd
2023/09/1217 : 30RNS Non-RegulatoryHutchmed (China) Limited Phase IIIb Savolitinib Results at WCLC 2023LSE:0J7GHutchison China Meditech Ltd
2023/09/1215 : 00RNS Non-RegulatoryHutchmed (China) Limited Patient Enrollment Completed for Bridging StudyLSE:0J7GHutchison China Meditech Ltd
2023/08/3117 : 30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
2023/08/2915 : 00RNS Non-RegulatoryHutchmed (China) Limited BTD in China for Savolitinib for Gastric CancerLSE:0J7GHutchison China Meditech Ltd
2023/08/2115 : 00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
2023/08/0717 : 30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorLSE:0J7GHutchison China Meditech Ltd
2023/07/3120 : 00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
2023/07/2015 : 00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for FruquintinibLSE:0J7GHutchison China Meditech Ltd
2023/07/1317 : 30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeLSE:0J7GHutchison China Meditech Ltd
2023/07/1015 : 00RNS Non-RegulatoryHutchmed (China) Limited Phase 1 Study of HMPL-415 InitiatedLSE:0J7GHutchison China Meditech Ltd
2023/06/2917 : 30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
2023/06/2617 : 30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
2023/06/1615 : 00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetLSE:0J7GHutchison China Meditech Ltd
2023/06/1523 : 39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMALSE:0J7GHutchison China Meditech Ltd
2023/06/0918 : 30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at EHA and ICMLLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

最近閲覧した銘柄

BIT
UC3F9N
Unicredit Bank
HITB
DORBTC
DoradoToken
LSE
UKDV
Spdr Uk Div
NASDAQ
ENBXX
Enterprise Money Market Portfoli
BIT
UC3F9H
Unicredit Bank
USOTC
NEXHY
Nippon Express (PK)
COIN
BULLLLLLUST
Bitbull
USOTC
BASA
Basanite (QB)
NYSE
SSPX
Janus Detroit St
BIT
UC0Q3H
Unicredit Bank
BOV
PETRD50
PETRD50 Ex:47,12
TSX
2238
Daiwa Asset Management
ASX
BXBIOB
BIT
P21S66
NLBNPIT21S66 20241220 24
MRTX
NANJETH
NANJCOIN
COIN
PCHGBP
POPCHAIN CASH
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有